ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,235
-0,77%
Bitcoin
57 484,48
-5,14%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sanara MedTech Inc (SMTI)

  7. Sanara MedTech Inc (SMTI) Actualités

SMTI Sanara MedTech Inc

31,84
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:07
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Sanara MedTech Inc SMTI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 31,84 13:00:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
31,84
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202415:15GLOBESanara MedTech Inc. Announces First Quarter Earnings Release..
18/4/202415:15GLOBESanara MedTech Inc. Announces $55 Million Debt Facility
05/4/202415:00GLOBESanara MedTech Inc. Announces the Appointments of Jake..
25/3/202421:05GLOBESanara MedTech Inc. Announces Fourth Quarter and Full Year..
13/3/202414:15GLOBESanara MedTech Inc. Announces Fourth Quarter and Full Year..
11/3/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:01EDGAR2Form 8-K - Current report
22/2/202415:15GLOBESanara MedTech Inc. Announces Unaudited Preliminary Results..
06/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:15GLOBESanara MedTech Inc. Announces Exclusive License Agreement..
30/11/202315:15GLOBESanara MedTech Inc. Announces the Publication of a 5,335..
13/11/202322:42EDGAR2Form 8-K - Current report
13/11/202322:05GLOBESanara MedTech Inc. Announces Third Quarter 2023 Results
13/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202314:15GLOBESanara MedTech Inc. Announces Third Quarter Earnings Release..
10/10/202315:15GLOBESanara MedTech Announces First Sale of ALLOCYTE® Plus..
22/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202314:00EDGAR2Form 8-K - Current report
12/9/202315:15GLOBESanara MedTech to Participate in Two Upcoming Conferences
16/8/202312:02EDGAR2Form 8-K - Current report
14/8/202323:11EDGAR2Form 8-K - Current report
14/8/202322:05GLOBESanara MedTech Inc. Announces Second Quarter 2023 Results
14/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form D - Notice of Exempt Offering of Securities
02/8/202315:20EDGAR2Form 8-K - Current report
02/8/202315:15GLOBESanara MedTech Inc. Announces the Acquisition of Certain..
01/8/202322:05GLOBESanara MedTech Inc. Announces Second Quarter Earnings..
15/5/202322:15GLOBESanara MedTech Inc. Announces First Quarter 2023 Results
03/5/202315:15GLOBESanara MedTech Inc. Announces First Quarter Earnings Release..

Dernières Valeurs Consultées

NASDAQ
SMTI
Sanara MedTech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés